Peri-implantitis Market

Peri-implantitis Market – Overview

The global peri-implantitis market is expected to expand at a healthy rate from 2021 to 2031 (forecast period). The increased use of dental implants for prosthetic rehabilitation is a major factor expected to boost the global peri-implantitis market during the forecast period. Growing awareness about oral hygiene has resulted in an increase in dental visits, which is projected to generate growth prospects in the peri-implantitis market.

Moreover, the aging population is expected to play a significant role in raising the demand for peri-implantitis treatment during the forecast period. The increasing smoking rate and growing tobacco causes several oral diseases, which is anticipated to boost the demand for peri-implantitis treatment. Furthermore, the advancement of technology has resulted in numerous dental techniques such as dental grafting, which are projected to create attractive opportunities for players operating in the peri-implantitis market.

Peri-implantitis Market – Competitive Landscape

Key players in the global peri-implantitis market are Pfizer Inc.; R.N. Laboratories Pvt. Ltd., Prachi Pharmaceuticals Private Limited., Basic Pharma Life Science Pvt. Ltd., Geistlich Pharma Inc., Cadila Pharmaceuticals, and Healthy Life Pharma.

The global peri-implantitis market is quite competitive. One of the main causes of market competition is the rapid growth of technology in the development of anti-infective medications and treatments. Furthermore, several companies are collaborating to develop drugs in order to get their products to market faster.

Peri-implantitis Market – Trends and Opportunities

Peri-implantitis is a dangerous inflammatory disease that affects hard and soft tissues near osseointegrated implants, inducing bone volume loss and the creation of peri-implant pockets. The success rate of dental implants was observed to be 92–98% over ten years. However, factors such as an increase in patients with a history of periodontitis, advancements in the treatment of peri-implantitis are expected to propel the global peri-implantitis market. Moreover, an increase in the patient population susceptible to smoking and diabetes is projected to support market growth.

With the rising number of implants being placed worldwide, the prevalence of peri-implant complications is projected to climb. As per the NCBI, the number of implants increased by 14.0% each year in the United States from 1999 to 2017. In the United Kingdom, around 2,60,000 implants are placed each year, indicating the increased need for dental implants. As implants become more popular, the prevalence of related diseases such as peri-implantitis and peri-implant mucositis shows a positive connection. Furthermore, as per the CDC, 47.2% of individuals aged 30 years in the United States had some kind of periodontal disorder in 2019. Men are more vulnerable to the disorder than women since they are more prone to smoking and health issues such as diabetes. Moreover, improvements like guided bone regeneration (GBR), laser debridement, and diagnostic genetic biomarker technique are anticipated to support the global peri-implantitis market growth.

Peri-implantitis Market – Regional Landscape

Europe is estimated to grow in the peri-implantitis market due to an increasing patient group with periodontal diseases, technical breakthroughs, and expanding public awareness regarding dental implants and related diseases. Moreover, European National Health Services cover dental implants and related therapies for individuals suffering from serious periodontal diseases that impair the supporting structures of teeth. Such factors are projected to drive the growth of the peri-implantitis market in the region.

The peri-implantitis market in Asia Pacific is anticipated to grow owing to a large population, favorable government efforts, and the availability of improved treatment centers in the region. Dental Implants (DIs) are routinely prescribed by dental professionals to replace the missing natural teeth and are attaining significance in populous countries such as China and India. Furthermore, China and India are currently the biggest tobacco-producing and consuming countries, with the lowest smoking awareness.